Hospital News and Research

RSS

eMix announces additional list of medical facilities that are taking part in beta trials

eMix, a new business venture incubated by DR Systems, today announced an additional list of medical facilities that are taking part in beta trials of eMix, the cloud-based technology for sharing imaging studies and reports. Earlier, eMix had announced a partial list of participating facilities.

5 Mar 2010

RMHC to host "Caring Calls for Kids" Phone Bank to improve health and well-being of children

Ronald McDonald House Charities (RMHC®) of the Philadelphia Region will be hosting a "Caring Calls for Kids" Phone Bank on Tuesday, March 9, 2010 from 3:00 p.m. to 8:00 p.m. with CBS 3 and The CW Philly.

5 Mar 2010

Porter Adventist Hospital designated as Blue Distinction Center for spine surgery, knee and hip replacement programs

Porter Adventist Hospital is among the first in the country to receive designation as Blue Distinction Centers in two surgical services that have recently been added to the Blue Cross and Blue Shield Association's expansion of its Blue Distinction® designation.

5 Mar 2010

Genetic epidemiology: Importance of population genomics

Did women and men contribute equally to the lineage of contemporary populations? Did our ancestors, Homo sapiens, lean more toward polygamy or monogamy? To answer these questions, Dr. Damian Labuda, an investigator at the Sainte-Justine University Hospital Research Center and a professor at the Department of Pediatrics of the Universit- de Montr-al, headed a team that analyzed genomic data from three population samples of African, Asian and European origin. The study's findings are published in the most recent issue of the American Journal of Human Genetics.

5 Mar 2010

People with skin of color more prone to dermatologic problems than those with lighter skin tones

According to projections from the United States Census Bureau, people with skin of color will comprise approximately half of the U.S. population by 2050. This group, which includes African-Americans, Asians, Latinos and other ethnicities, are more prone to certain dermatologic problems than those with lighter skin tones due to their genetic make-up and in some cases cultural practices.

5 Mar 2010

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life. The lack of exposure to worm infections, as a result of improved living standards and medical conditions, might have contributed to the increased incidence of IBD in the Western world.

5 Mar 2010

Harmful health IT malfunctions

With the new health care IT technology already in use, preparation for the accompanying consequences should be on every family’s mind, advises Martine Ehrenclou, author of the multiple award-winning, self-help guide Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive (Lemon Grove Press).

5 Mar 2010

Health Discovery delivers letter of gratitude and support to Congressman Edolphus Towns for holding congressional hearing

Health Discovery Corporation announced today that it delivered a letter of gratitude and support to Congressman Edolphus Towns, Chairman of the House Committee on Oversight and Government Reform for holding today, March 4, 2010, a congressional hearing on “Prostate Cancer: New Questions About Screening and Treatment.”

5 Mar 2010

Endothelial cells can produce copious amounts of adult stem cells: Study

In a leap toward making stem cell therapy widely available, researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College have discovered that endothelial cells, the most basic building blocks of the vascular system, produce growth factors that can grow copious amounts of adult stem cells and their progeny over the course of weeks.

5 Mar 2010

Recipients for 2010 Scholar Awards announced

The American Society of Hematology announces the 2010 recipients of its Scholar Awards. The program is designed to support hematologists who have chosen a career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator.

5 Mar 2010

Researchers discover key reason why form of leukemia progresses from chronic phase to blast crisis

Researchers have discovered a key reason why a form of leukemia progresses from its more-treatable chronic phase to a life-threatening phase called blast crisis.

5 Mar 2010

HMS study suggests new targets for treating Angelman syndrome

Angelman Syndrome is a rare but serious genetic disorder that causes a constellation of developmental problems in affected children, including mental retardation, lack of speech, and in some cases, autism. Over a decade ago, researchers found that AS was caused by mutation in a single gene, but no one had been able to explain how this defect resulted in the debilitating neurological symptoms of the disease.

5 Mar 2010

TSO3 new generation sterilizers allowed CE Mark labeling

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings using ozone, today announced that documentation supplied to the European Notified Body conforms to the new Medical Device Directive for Class IIb medical devices; an enhanced European standard to be enforced starting April 2010. This notification allows the Company to label its new generation sterilizers with the CE Mark, which is a requirement to place products in the European Union; the second largest sterilization market after the United States.

5 Mar 2010

Apixaban superior to enoxaparin in reducing venous thromboembolism in total knee replacement surgery patients

Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.

5 Mar 2010

Gene involved in susceptibility and resistance to TB identified

University of Washington researchers have identified a gene involved in susceptibility and resistance to tuberculosis. This same gene, they have found, has a role in the severity of leprosy, which is caused by a related pathogen. The researchers also have learned why this gene is important for susceptibility.

5 Mar 2010

Hospitals across the nation celebrate National Nutrition Month

Hospitals across the nation are celebrating National Nutrition Month by changing their food service offerings and staging events to draw more attention to their participation in the Health Care Without Harm Balanced Menus program, which advocates a "Less Meat, Better Meat" approach to hospital food service operations.

5 Mar 2010

Healthland introduces new Healthland Analytics solution for hospitals

Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announces its new Healthland Analytics solution. Developed in partnership with Performance Management Institute (PMI), Healthland Analytics extracts relevant data from the Healthland Financial System solutions and other sources and presents it in easy-to-grasp, actionable snapshots of financial, operational and clinical performance.

5 Mar 2010

RMEI, PIM jointly sponsor virtual lecture to address the need for education on ALL in AYAs

Currently, no definitive standard of care exists for adolescent and young adults (AYA) with acute lymphoblastic leukemia (ALL). Recent research suggests that AYAs treated with pediatric treatment protocols have better outcomes than those treated with adult treatment protocols.

5 Mar 2010

Diamedix and Delta Biologicals’ suite of diagnostic tests: Fumouze Diagnostics to be exclusive distributor in France

IVAX Diagnostics, Inc., a fully integrated global in vitro diagnostics company, announced that Diamedix Corporation has signed a distribution agreement with Fumouze Diagnostics, a division of Sofibel S.A.S., of Paris, France, pursuant to which Fumouze Diagnostics will be the exclusive third party distributor of Diamedix Corporation and Delta Biologicals S.r.l.’s suite of diagnostic tests in France. Diamedix is a U.S. subsidiary of IVAX Diagnostics and Delta Biologicals is IVAX Diagnostics’ subsidiary located in Italy. The initial term of the distribution agreement is three years.

5 Mar 2010

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

The second American Association for Cancer Research Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic provides attendees with an overview of the most advanced cancer research in a variety of fields, including the tumor microenvironment, microRNAs, signal transduction and novel therapeutic development.

5 Mar 2010

Hospital News and Research

eMix announces additional list of medical facilities that are taking part in beta trials

RMHC to host "Caring Calls for Kids" Phone Bank to improve health and well-being of children

Porter Adventist Hospital designated as Blue Distinction Center for spine surgery, knee and hip replacement programs

Genetic epidemiology: Importance of population genomics

People with skin of color more prone to dermatologic problems than those with lighter skin tones

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

Harmful health IT malfunctions

Health Discovery delivers letter of gratitude and support to Congressman Edolphus Towns for holding congressional hearing

Endothelial cells can produce copious amounts of adult stem cells: Study

Recipients for 2010 Scholar Awards announced

Researchers discover key reason why form of leukemia progresses from chronic phase to blast crisis

HMS study suggests new targets for treating Angelman syndrome

TSO3 new generation sterilizers allowed CE Mark labeling

Apixaban superior to enoxaparin in reducing venous thromboembolism in total knee replacement surgery patients

Gene involved in susceptibility and resistance to TB identified

Hospitals across the nation celebrate National Nutrition Month

Healthland introduces new Healthland Analytics solution for hospitals

RMEI, PIM jointly sponsor virtual lecture to address the need for education on ALL in AYAs

Diamedix and Delta Biologicals’ suite of diagnostic tests: Fumouze Diagnostics to be exclusive distributor in France

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News